Buy stocks
Invest and track all your stocks in one place.
Wockhardt LtdNSE: WOCKPHARMA
NSE: WOCKPHARMA
₹1,728.60
-4.4
(6:01 am IST)
-0.3%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹1,728.60
Today’s high
₹1,750.00
Today’s low
₹1,711.10
52W high
₹1,868.80
52W low
₹750.00
1Y
122.7%
PE
-572.38
PB
6.46
EPS (TTM)
-3.02
Dividend yield
NA
5Y
48.4%
Market cap
₹28,108.4 Cr
Volume
1,30,271
Average volume
9,00,912
Insights
WOCKPHARMA has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
WOCKPHARMA price is above its 200 day moving average
WOCKPHARMA PE is in the low end of its range over the past 2 years
WOCKPHARMA PE is in the lowest 10% across all stocks. The market is valuing it as a value stock on an earnings basis.
WOCKPHARMA has negative earnings and hence the PE is not defined
WOCKPHARMA is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
₹1,728.60
₹6,600.00
₹1,677.60
₹1,880.50
₹1,243.50
₹1,109.00
1D
-0.3%
-1.3%
-0.9%
-2.1%
-1.3%
-2.6%
1Y
+122.7%
+45.9%
+6.9%
+5.3%
-6.1%
-16.7%
PE
-572.38
79.94
36.80
26.23
18.34
18.54
PB
6.46
11.70
5.57
5.00
3.11
1.97
EPS
0.00
0.00
0.00
0.00
0.00
0.00
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2024
Revenue
₹2,915.0 Cr
Net income
- ₹47.0 Cr
See stock holdings
Top institutional holders
Tata Asset Management Limited
2.13%
Vanguard Group Inc
1.48%
HDFC Asset Management Co Ltd
1.17%
Electrum Portfolio Managers Pvt Ltd.
1.16%
Macquarie Investment Management Advisers
1.08%
Top mutual fund holders
Tata Small Cap Fund
1.19%
HSBC Small Cap Fund
0.82%
Vanguard Total Intl Stock Idx Fund
0.69%
Vanguard Emerging Markets Stock Idx Fund
0.61%
Tata Large & Mid Cap
0.60%
About Wockhardt
Wockhardt Ltd is a drug manufacturing company focusing on pharmaceutical and biotechnology products. The group is involved in new drug discovery, contract manufacturing, API, vaccines, and branded pharmaceuticals business. In addition, it operates a chain of super-specialty hospitals. Its novel antibiotic platform has various assets, such as Zaynich (WCK 5222); Miqnaf (Nafithromycin), a macrolide-class respiratory antibiotic; Ertapenem-Zidebactam (WCK 6777); Foviscu (WCK 2482), an antibiotic for Gram-negative infections; and Odrate (WCK 6777), among others. The group is mainly engaged in the pharmaceutical business, which is considered its only reportable business segment. Geographically, it generates maximum revenue from Europe, followed by India, the USA, and the Rest of the world.
Company address
Bandra-Kurla Complex, Wockhardt Towers, Mumbai, MH, 400051
Key executives
Name
Title
Age
Dr. Habil Fakhruddin Khorakiwala
CEO/Chairman of the Board/Director/Founder
NA
Dr. Murtaza Habil Khorakiwala
Director/Managing Director
50 yrs

FAQs

How to Buy Wockhardt Ltd Stock?
What is the Share Price of Wockhardt Ltd?
What is the Market Cap of Wockhardt Ltd?
In which sector / industry does Wockhardt Ltd operate?
What was the revenue of Wockhardt Ltd?
What is the PE ratio of Wockhardt Ltd?
What is the 52 week high price of Wockhardt Ltd?
What is the 52 week low price of Wockhardt Ltd?
Can fractional shares of Wockhardt Ltd be purchased?